AURORA LABS LIMITED — Director's Dealing 2017

Jul 25, 2017

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity: AURORA LABS LIMITED

ABN: 44 601 164 505

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mathew Whyte
Date of appointment	26 July 2017

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

N/A

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature ofinterestNote: Provide details of the circumstances giving riseto the relevant interest.M&S Whyte <Family A/c>Mr Whyte is a trustee andbeneficiary	Number & class of Securities50,000 Unquoted Options (Ex $3.00/Expiry31/3/2020)

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Offer made subject to shareholder approval atthe next Annual General Meeting pursuant tothe Aurora Labs Ltd Employee Incentive Plan
Nature of interest	Direct
Name of registered holder(if issued securities)	N/A
No. and class of securities towhich interest relates	100,000 Unquoted Options to be issued subjectto shareholder approval to be exercisable at$0.95 and expiring on 31 July 2020.

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002